Form 8-K - Current report:
SEC Accession No. 0000950103-20-000533
Filing Date
2020-01-13
Accepted
2020-01-13 07:03:45
Documents
25
Period of Report
2020-01-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dp119156_8k.htm   iXBRL 8-K 26451
2 EXHIBIT 99.1 dp119156_ex9901.htm EX-99.1 32299
3 GRAPHIC image_002.jpg GRAPHIC 388116
4 GRAPHIC image_003.jpg GRAPHIC 524491
5 GRAPHIC image_004.jpg GRAPHIC 446055
6 GRAPHIC image_005.jpg GRAPHIC 403046
7 GRAPHIC image_006.jpg GRAPHIC 293220
8 GRAPHIC image_007.jpg GRAPHIC 393273
9 GRAPHIC image_008.jpg GRAPHIC 416200
10 GRAPHIC image_009.jpg GRAPHIC 451970
11 GRAPHIC image_010.jpg GRAPHIC 423045
12 GRAPHIC image_011.jpg GRAPHIC 453263
13 GRAPHIC image_012.jpg GRAPHIC 462420
14 GRAPHIC image_013.jpg GRAPHIC 489564
  Complete submission text file 0000950103-20-000533.txt   7333405

Data Files

Seq Description Document Type Size
15 XBRL SCHEMA FILE bhc-20200113.xsd EX-101.SCH 3195
16 XBRL LABEL FILE bhc-20200113_lab.xml EX-101.LAB 34591
17 XBRL PRESENTATION FILE bhc-20200113_pre.xml EX-101.PRE 22717
18 EXTRACTED XBRL INSTANCE DOCUMENT dp119156_8k_htm.xml XML 3594
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Filer) CIK: 0000885590 (see all company filings)

EIN.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 20522736
SIC: 2834 Pharmaceutical Preparations